Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes

Journal of Virology

Volumn 89, Issue 8, 2015, Pages 4504-4516

  Byrd Leotis, Lauren ^a   Galloway, Summer E ^a,b   Agbogu, Evangeline ^a   Steinhauer, David A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; LUCIFERASE;

ACIDITY; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; INFLUENZA VIRUS A; MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PH; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN STRUCTURE; VIRUS STRAIN; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CHLOROCEBUS AETHIOPS; GENETIC VARIABILITY; GENETICS; HAMSTER; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; MOLECULAR CLONING; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN CONFORMATION; SPECIES DIFFERENCE; VERO CELL LINE;

AVES; INFLUENZA A VIRUS;

ANIMALS; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; CRICETINAE; DNA MUTATIONAL ANALYSIS; GENETIC VARIATION; HEMAGGLUTININS; HYDROGEN-ION CONCENTRATION; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; LUCIFERASES; MODELS, MOLECULAR; MUTAGENESIS; MUTATION; PHENOTYPE; PROTEIN CONFORMATION; PROTEIN STABILITY; SPECIES SPECIFICITY; VERO CELLS;

EID: 84925427993     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00057-15     Document Type: Article

References (71)

1. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-179.
2. Herfst S, Imai M, Kawaoka Y, Fouchier RA. 2014. Avian influenza virus transmission to mammals. Curr Top Microbiol Immunol 385:137-155. http://dx.doi.org/10.1007/82_2014_387.
3. de Jong JC, Claas EC, Osterhaus AD, Webster RG, Lim WL. 1997. A pandemic warning? Nature 389:554. http://dx.doi.org/10.1038/39218.
4. Hien TT, de Jong M, Farrar J. 2004. Avian influenza: a challenge to global health care structures. N Engl J Med 351:2363-2365. http://dx.doi.org/10.1056/NEJMp048267.
5. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368:1888-1897. http://dx.doi.org/10.1056/NEJMoa1304459.
6. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477. http://dx.doi.org/10.1016/S0140-6736(97)11212-0.
7. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY, Writing Committee of the World Health Organization Consultation on Human Influenza. 2005. Avian influenza A (H5N1) infection in humans. N Engl J Med 353:1374-1385. http://dx.doi.org/10.1056/NEJMra052211.
8. Almond JW. 1977. A single gene determines the host range of influenza virus. Nature 270:617-618. http://dx.doi.org/10.1038/270617a0.
9. Oxford JS, McGeoch DJ, Schild GC, Beare AS. 1978. Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature 273:778-779. http://dx.doi.org/10.1038/273778a0.
10. Scholtissek C, Burger H, Kistner O, Shortridge KF. 1985. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 147:287-294. http://dx.doi.org/10.1016/0042-6822(85)90131-X.
11. Scholtissek C, Koennecke I, Rott R. 1978. Host range recombinants of fowl plague (influenza A) virus. Virology 91:79-85. http://dx.doi.org/10.1016/0042-6822(78)90356-2.
12. Scholtissek C, Murphy BR. 1978. Host range mutants of an influenza A virus. Arch Virol 58:323-333. http://dx.doi.org/10.1007/BF01317824.
13. Snyder MH, Buckler-White AJ, London WT, Tierney EL, Murphy BR. 1987. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys. J Virol 61:2857-2863.
14. Snyder MH, Clements ML, De Borde D, Maassab HF, Murphy BR. 1985. Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus. J Clin Microbiol 22:719-725.
15. Snyder MH, Betts RF, DeBorde D, Tierney EL, Clements ML, Herrington D, Sears SD, Dolin R, Maassab HF, Murphy BR. 1988. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol 62:488-495.
16. Chanock RM, Murphy BR, Collins PL, Coelingh KV, Olmsted RA, Snyder MH, Spriggs MK, Prince GA, Moss B, Flores J, et al. 1988. Live viral vaccines for respiratory and enteric tract diseases. Vaccine 6:129-133. http://dx.doi.org/10.1016/S0264-410X(88)80014-8.
17. de Wit E, Kawaoka Y, de Jong MD, Fouchier RA. 2008. Pathogenicity of highly pathogenic avian influenza virus in mammals. Vaccine 26(Suppl 4):D54-D58. http://dx.doi.org/10.1016/j.vaccine.2008.07.072.
18. Steinhauer DA, Skehel JJ. 2002. Genetics of influenza viruses. Annu Rev Genet 36:305-332. http://dx.doi.org/10.1146/annurev.genet.36.052402.152757.
19. Russell CA, Fonville JM, Brown AE, Burke DF, Smith DL, James SL, Herfst S, van Boheemen S, Linster M, Schrauwen EJ, Katzelnick L, Mosterin A, Kuiken T, Maher E, Neumann G, Osterhaus AD, Kawaoka Y, Fouchier RA, Smith DJ. 2012. The potential for respiratory droplettransmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 336:1541-1547. http://dx.doi.org/10.1126/science.1222526.
20. Brown EG, Liu H, Kit LC, Baird S, Nesrallah M. 2001. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci USA 98:6883-6888. http://dx.doi.org/10.1073/pnas.111165798.
21. de Graaf M, Fouchier RA. 2014. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J 33:823-841. http://dx.doi.org/10.1002/embj.201387442.
22. Wilks S, de Graaf M, Smith DJ, Burke DF. 2012. A review of influenza haemagglutinin receptor binding as it relates to pandemic properties. Vaccine 30:4369-4376. http://dx.doi.org/10.1016/j.vaccine.2012.02.076.
23. Mair CM, Ludwig K, Herrmann A, Sieben C. 2014. Receptor binding andpHstability: how influenzaAvirus hemagglutinin affects host-specific virus infection. Biochim Biophys Acta 1838:1153-1168. http://dx.doi.org/10.1016/j.bbamem.2013.10.004.
24. Xiong X, McCauley JW, Steinhauer DA. 2014. Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range. Curr Top Microbiol Immunol 385:63-91. http://dx.doi.org/10.1007/82_2014_423.
25. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. 1994. Receptor specificity in human, avian, and equineH2andH3influenza virus isolates. Virology 205:17-23. http://dx.doi.org/10.1006/viro.1994.1615.
26. Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 74:8502-8512. http://dx.doi.org/10.1128/JVI.74.18.8502-8512.2000.
27. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. 2013. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9:e1003151. http://dx.doi.org/10.1371/journal.ppat.1003151.
28. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428. http://dx.doi.org/10.1038/nature10831.
29. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541. http://dx.doi.org/10.1126/science.1213362.
30. Reed ML, Bridges OA, Seiler P, Kim JK, Yen HL, Salomon R, Govorkova EA, Webster RG, Russell CJ. 2010. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol 84:1527-1535. http://dx.doi.org/10.1128/JVI.02069-09.
31. DuBois RM, Zaraket H, Reddivari M, Heath RJ, White SW, Russell CJ. 2011. Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity. PLoS Pathog 7:e1002398. http://dx.doi.org/10.1371/journal.ppat.1002398.
32. Shelton H, Roberts KL, Molesti E, Temperton N, Barclay WS. 2013. Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility. The J Gen Virol 94:1220-1229. http://dx.doi.org/10.1099/vir.0.050526-0.
33. Collins PJ, Vachieri SG, Haire LF, Ogrodowicz RW, Martin SR, Walker PA, Xiong X, Gamblin SJ, Skehel JJ. 2014. Recent evolution of equine influenza and the origin of canine influenza. Proc Natl Acad Sci U S A 111:11175-11180. http://dx.doi.org/10.1073/pnas.1406606111.
34. Koerner I, Matrosovich MN, Haller O, Staeheli P, Kochs G. 2012. Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus. The J Gen Virol 93:970-979. http://dx.doi.org/10.1099/vir.0.035782-0.
35. Bottcher-Friebertshauser E, Garten W, Matrosovich M, Klenk HD. 2014. The hemagglutinin: a determinant of pathogenicity. Curr Top Microbiol Immunol 385:3-34. http://dx.doi.org/10.1007/82_2014_384.
36. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, Sun X, Carney PJ, Villanueva JM, Stevens J, Katz JM, Tumpey TM. 2013. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501:556-559. http://dx.doi.org/10.1038/nature12391.
37. Klenk HD, Rott R, Orlich M, Blodorn J. 1975. Activation of influenza A viruses by trypsin treatment. Virology 68:426-439. http://dx.doi.org/10.1016/0042-6822(75)90284-6.
38. Lazarowitz SG, Choppin PW. 1975. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68:440-454. http://dx.doi.org/10.1016/0042-6822(75)90285-8.
39. Appleyard G, Maber HB. 1974. Plaque formation by influenza viruses in the presence of trypsin. J Gen Virol 25:351-357. http://dx.doi.org/10.1099/0022-1317-25-3-351.
40. Wilson IA, Skehel JJ, Wiley DC. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289: 366-373. http://dx.doi.org/10.1038/289366a0.
41. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. 1998. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409-417. http://dx.doi.org/10.1016/S0092-8674(00)81771-7.
42. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43. http://dx.doi.org/10.1038/371037a0.
43. Scholtissek C. 1985. Stability of infectious influenza A viruses to treatment at low pH and heating. Arch Virol 85:1-11. http://dx.doi.org/10.1007/BF01317001.
44. Scholtissek C. 1985. Stability of infectious influenza A viruses at low pH and at elevated temperature. Vaccine 3:215-218. http://dx.doi.org/10.1016/0264-410X(85)90109-4.
45. Ruigrok RW, Martin SR, Wharton SA, Skehel JJ, Bayley PM, Wiley DC. 1986. Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology 155:484-497. http://dx.doi.org/10.1016/0042-6822(86)90210-2.
46. Carr CM, Chaudhry C, Kim PS. 1997. Influenza hemagglutinin is springloaded by a metastable native conformation. Proc Natl Acad Sci U S A 94:14306-14313. http://dx.doi.org/10.1073/pnas.94.26.14306.
47. Haywood AM, Boyer BP. 1986. Time and temperature dependence of influenza virus membrane fusion at neutral pH. J Gen Virol 67(Pt 12): 2813-2817.
48. Fischer H, Widdicombe JH. 2006. Mechanisms of acid and base secretion by the airway epithelium. J Membr Biol 211:139-150. http://dx.doi.org/10.1007/s00232-006-0861-0.
49. Fischer H, Widdicombe JH, Illek B. 2002. Acid secretion and proton conductance in human airway epithelium. Am J Physiol Cell Physiol 282: C736-C743. http://dx.doi.org/10.1152/ajpcell.00369.2001.
50. O'Donnell CD, Vogel L, Matsuoka Y, Jin H, Subbarao K. 2014. The matrix gene segment destabilizes the Acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. J Virol 88:12374-12384. http://dx.doi.org/10.1128/JVI.01107-14.
51. Weis WI, Cusack SC, Brown JH, Daniels RS, Skehel JJ, Wiley DC. 1990. The structure of a membrane fusion mutant of the influenza virus haemagglutinin. EMBO J 9:17-24.
52. Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC, Hay AJ. 1991. Amantadine selection of a mutant influenza virus containing an acidstable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A 88:11525-11529. http://dx.doi.org/10.1073/pnas.88.24.11525.
53. Steinhauer DA, Martin J, Lin YP, Wharton SA, Oldstone MB, Skehel JJ, Wiley DC. 1996. Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc Natl Acad Sci U S A 93:12873-12878. http://dx.doi.org/10.1073/pnas.93.23.12873.
54. Thoennes S, Li ZN, Lee BJ, Langley WA, Skehel JJ, Russell RJ, Steinhauer DA. 2008. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. Virology 370:403-414. http://dx.doi.org/10.1016/j.virol.2007.08.035.
55. Reed ML, Yen HL, DuBois RM, Bridges OA, Salomon R, Webster RG, Russell CJ. 2009. Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. J Virol 83:3568-3580. http://dx.doi.org/10.1128/JVI.02238-08.
56. Cross KJ, Wharton SA, Skehel JJ, Wiley DC, Steinhauer DA. 2001. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.EMBOJ 20:4432-4442. http://dx.doi.org/10.1093/emboj/20.16.4432.
57. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC. 1985. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40:431-439. http://dx.doi.org/10.1016/0092-8674(85)90157-6.
58. Zaraket H, Bridges OA, Russell CJ. 2013. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice. J Virol 87:4826-4834. http://dx.doi.org/10.1128/JVI.03110-12.
59. Ha Y, Stevens DJ, Skehel JJ, Wiley DC. 2002. H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. EMBO J 21:865-875. http://dx.doi.org/10.1093/emboj/21.5.865.
60. Russell RJ, Gamblin SJ, Haire LF, Stevens DJ, Xiao B, Ha Y, Skehel JJ. 2004. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325:287-296. http://dx.doi.org/10.1016/j.virol.2004.04.040.
61. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56: 365-394. http://dx.doi.org/10.1146/annurev.bi.56.070187.002053.
62. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569. http://dx.doi.org/10.1146/annurev.biochem.69.1.531.
63. Russell RJ, Kerry PS, Stevens DJ, Steinhauer DA, Martin SR, Gamblin SJ, Skehel JJ. 2008. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci U S A 105:17736-17741. http://dx.doi.org/10.1073/pnas.0807142105.
64. Bodian DL, Yamasaki RB, Buswell RL, Stearns JF, White JM, Kuntz ID. 1993. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32:2967-2978. http://dx.doi.org/10.1021/bi00063a007.
65. Kumru OS, Joshi SB, Smith DE, Middaugh CR, Prusik T, Volkin DB. 2014. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals 42:237-259. http://dx.doi.org/10.1016/j.biologicals.2014.05.007.
66. Wang W, Lu B, Zhou H, Suguitan AL, Jr, Cheng X, Subbarao K, Kemble G, Jin H. 2010. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J Virol 84:6570-6577. http://dx.doi.org/10.1128/JVI.00221-10.
67. Krenn BM, Egorov A, Romanovskaya-Romanko E, Wolschek M, Nakowitsch S, Ruthsatz T, Kiefmann B, Morokutti A, Humer J, Geiler J, Cinatl J, Michaelis M, Wressnigg N, Sturlan S, Ferko B, Batishchev OV, Indenbom AV, Zhu R, Kastner M, Hinterdorfer P, Kiselev O, Muster T, Romanova J. 2011. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS One 6:e18577. http://dx.doi.org/10.1371/journal.pone.0018577.
68. Cotter CR, Jin H, Chen Z. 2014. A single amino acid in the stalk region of the H1N1pdm influenza virusHAprotein affects viral fusion, stability and infectivity. PLoS Pathog 10:e1003831. http://dx.doi.org/10.1371/journal.ppat.1003831.
69. Coenen F, Tolboom JT, Frijlink HW. 2006. Stability of influenza subunit vaccine. Does a couple of days outside the refrigerator matter? Vaccine 24:525-531. http://dx.doi.org/10.1016/j.vaccine.2005.07.081.
70. Hickey JM, Holtz KM, Manikwar P, Joshi SB, McPherson CE, Buckland B, Srivastava IK, Middaugh CR, Volkin DB. 2014. Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage. J Pharm Sci 103:821-827. http://dx.doi.org/10.1002/jps.23848.
71. Wang W, Suguitan AL, Jr, Zengel J, Chen Z, Jin H. 2012. Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage. Vaccine 30:872-878. http://dx.doi.org/10.1016/j.vaccine.2011.11.101.